Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ERG encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. Additionally we are shipping V-Ets erythroblastosis Virus E26 Oncogene Homolog (Avian) Proteins (11) and V-Ets erythroblastosis Virus E26 Oncogene Homolog (Avian) Kits (3) and many more products for this protein.
Showing 10 out of 131 products:
Human Polyclonal ERG Primary Antibody for IHC (p), IHC - ABIN250916
Tomlins, Rhodes, Perner, Dhanasekaran, Mehra, Sun, Varambally, Cao, Tchinda, Kuefer, Lee, Montie, Shah, Pienta, Rubin, Chinnaiyan: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. in Science (New York, N.Y.) 2005
Nine primary prostate cancers that developed metachronous bone metastasis samples showed TMPRSS2 (show TMPRSS2 Antibodies)-ERG fusions, which were associated with increased ERG expression at immunohistochemistry. mTOR (show FRAP1 Antibodies) pathway activation was documented in 6 patients
Data indicate a significant prognostic role for assessing transcriptional regulator ERG (ERG) and phosphatase and tensin homolog protein (PTEN) in men with prostate cancer.
There was no statistically significant difference in the expression of the ERG between patients and controls. Also, no correlation was detected between the expression of this gene and age of onset, disease duration and Expanded Disability Status Scale.
Here, the authors show that ERG, through its physical interaction with androgen receptor (show AR Antibodies), induces AR aggregation and endoplasmic reticulum stress in the prostate glands of ERG transgenic mice.
Our results suggested that reduced expression of miR (show MLXIP Antibodies)-1271 may be involved in the ERG expression and that miR (show MLXIP Antibodies)-1271 could be a therapeutic target for ERG-positive prostate cancer patients
Evaluating the association between ERG expression and pathologic factors.
despite of their well-known adverse role in prognosis of AML (show RUNX1 Antibodies), neither BAALC (show BAALC Antibodies) nor ERG expression levels at diagnosis had effect on survival of AML (show RUNX1 Antibodies) patients who underwent allo-HSCT.
ERG expression is lo (show TGFB1 Antibodies)st in liver endothelial cells (show GARS Antibodies) from cirr (show SMAD3 Antibodies)hotic patients with fibrosis related to alcoholic liver disease or primary biliary cirrhosis and inversely correlates with increas (show SMAD3 Antibodies)ed markers of endothelial-to-mesenchymal transition.
ERG expression is of limited prognostic value in acute myeloid leukemia (show BCL11A Antibodies).
Our findings indicate that TGF-beta (show TGFB1 Antibodies) signaling is a major determinant of EMT (show ITK Antibodies) in T/E overexpressing LNCaP cells.
KLF2 (show KLF2 Antibodies) and ERG associate in a physical complex and the two proteins synergistically activate transcription of Flk1 (show KDR Antibodies).
fli1 (show FLI1 Antibodies), and etsrp (show ETV2 Antibodies), demonstrated that erg (show KCNH2 Antibodies) and fli1 (show FLI1 Antibodies) act cooperatively and are required for angiogenesis possibly via direct regulation of an endothelial cell junction molecule, VE-cadherin (show CDH5 Antibodies)
A combination of gain-of-function and loss-of-function studies suggested a redundant yet specific role for erg (show KCNH2 Antibodies) in both angioblast specification/proliferation and early angiogenesis, and a synergistic interaction with the critical ETS (show ETS1 Antibodies) factor etsrp (show ETV2 Antibodies).
ERG balances TGFbeta (show TGFB1 Antibodies) signalling through the SMAD1 (show SMAD1 Antibodies) and SMAD3 (show SMAD3 Antibodies) pathways, protecting the endothelium from endothelial-to-mesenchymal transition and consequent liver fibrosis in mice via a SMAD3 (show SMAD3 Antibodies)-dependent mechanism.
Reduced Erg dosage impairs survival of hematopoietic stem and progenitor cells.
loss of ERG and FLI1 (show FLI1 Antibodies) might contribute to the pathogenesis of vascular lung complications through the induction of inflammation.
Combined, these data suggest a possible pathway linking GDF5 (show GDF5 Antibodies), ERG and downstream factors in the processes of chondrocyte differentiation during articular joint formation.
Our study reveals that ERG has essential and cell autonomous roles in endothelial cell development and blood vessel maintenance.
We show that the gene expression signature specifically attributable to trisomy of Erg in the murine model is strongly correlated with gene expression changes in human Down syndrome hematopoietic cells.
Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg.
ERG plays a critical role in coordinating the balance between self-renewal and differentiation of HSCs.
ERG activates the transcriptional program regulated by YAP1 (show YAP1 Antibodies) of the Hippo signaling pathway and found that prostate-specific activation of either ERG or YAP1 (show YAP1 Antibodies) in mice induces similar transcriptional changes and results in age-related prostate tumors.
ERG and APLNR (show APLNR Antibodies) are essential for endothelial homeostasis in venules in the lung and that perturbation in ERG-APLNR (show APLNR Antibodies) signaling is crucial for the development of pulmonary veno-occlusive disease.
This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been identified.
, transcriptional regulator ERG
, transcriptional regulator ERG (transforming protein ERG)
, v-ets avian erythroblastosis virus E26 oncogene related
, v-ets erythroblastosis virus E26 oncogene homolog
, v-ets erythroblastosis virus E26 oncogene like
, avian erythroblastosis virus E-26 (v-ets) oncogene related
, vascular ETS factor
, erg gene (erg_E)
, v-ets erythroblastosis virus E26 oncogene homolog (avian)
, transcriptional regulator Erg